Tesamorelin
A synthetic analog of growth-hormone-releasing hormone (GHRH), studied in preclinical endocrine research.
Customers also frequently order with
What research has studied about Tesamorelin
Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH). In research models it is studied as a secretagogue — a molecule that acts on the pituitary to stimulate the release of endogenous growth hormone, rather than supplying growth hormone directly.
Laboratory research on tesamorelin has examined GHRH-receptor signalling and downstream growth-hormone and IGF-1 dynamics in cell and animal models. These are preclinical observations reported in the literature; nothing here describes use in humans.
Certificate of Analysis
Every Tesamorelin lot is tested by an independent third-party lab and ships with its lot-matched Certificate of Analysis. This lot’s certificate is available on request — contact us and we will send it over.
Specifications
| Compound | Tesamorelin |
| Available sizes | 5 mg, 10 mg |
| Form | Lyophilized powder |
| Purity | Measured by HPLC; see the Certificate of Analysis for the lot |
| Storage | Store cold and away from light per your lab protocol |
| Intended use | Laboratory and research use only |
Research context
For the published literature, search PubMed for “tesamorelin GHRH”. Steadfast supplies this material for laboratory research use only.
Frequently asked questions
What is tesamorelin?
Tesamorelin is a synthetic GHRH analog studied in preclinical endocrine research as a growth-hormone secretagogue. Steadfast supplies it as a lyophilized research material for laboratory use only.
What has research studied about tesamorelin?
Research has examined its interaction with the GHRH receptor and downstream growth-hormone/IGF-1 signalling in laboratory and animal models.
Is it intended for human use?
No. It is a research chemical for in-vitro laboratory research only, not a drug or supplement.